Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.240
-0.140 (-5.88%)
Jun 1, 2026, 11:47 AM EDT - Market open
Compass Therapeutics Employees
Compass Therapeutics had 39 employees as of December 31, 2025. The number of employees increased by 4 or 11.43% compared to the previous year.
Employees
39
Change (1Y)
4
Growth (1Y)
11.43%
Revenue / Employee
n/a
Profits / Employee
-$1,748,026
Market Cap
403.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | 4 | 11.43% |
| Dec 31, 2024 | 35 | 3 | 9.38% |
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 193 |
| Lyell Immunopharma | 161 |
| Neurogene | 131 |
| Century Therapeutics | 78 |
| Upstream Bio | 75 |
| Lexeo Therapeutics | 59 |
| X4 Pharmaceuticals | 45 |
| Zura Bio | 40 |
CMPX News
- 4 days ago - Compass Therapeutics to Participate in Upcoming June Investor Events - GlobeNewsWire
- 10 days ago - Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 12 days ago - Compass Therapeutics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 12 days ago - Compass Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 20 days ago - Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewsWire
- 27 days ago - Compass Therapeutics reports Q1 EPS (10c), consensus (10c) - TheFly
- 27 days ago - Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 27 days ago - Compass Therapeutics Earnings release: Q1 2026 - Filings